Anavex Life Sciences Corp (AVXL)

[nidan7500]

NEW M.F. piece re Pharma-BIO buyouts...stop me if you have heard this before:

"Second, Biogen has two particular assets under its roof that might trigger a buyout. Specifically, the biotech's experimental Alzheimer's candidate, aducanumab, sports the highest net present value among all clinical-stage drugs at a staggering $10.2 billion, according to a report by EvaluatePharma. If approved, this drug could turn out to be the best-selling medicine of all time by a wide margin.
The downside is that aducanumab belongs to a class of drugs that have repeatedly failed to show any signs of efficacy in pivotal-stage trials -- meaning that this drug is without a doubt a long shot. Still, big pharma has plowed literally billions into similar drugs time and again -- despite any lack of proof that they work. So it shouldn't come as a shock if aducanumab turns out to be a key reason Biogen gets taken out. "

YA Think? AVXL is reportedly working on a new drug which shocks users into REALITY...if one keeps trying the SAME thing, even though all clinical-historical evidence indicates certain failure...what is that called ???? What am I missing here?